G.L. Pharma GmbH

Exhibitor at CPHI Frankfurt 2022 stand 41L41, Finished Dosage Formulations
About Us

G.L. Pharma specializes in the development, registration, manufacture and marketing of pharmaceutical specialties. We are a family owned company based in Austria with two state-of-the-art production facilities and over 900 dedicated employees. Through our partners and branch offices we are active in more than 50 countries worldwide. Looking back on a history of 70 years our core therapeutic areas are: Pain Management, Addiction Therapy, Epilepsy and Depressive Disorders.

  • AT
  • 2015
    On CPHI since
  • 1000 - 4999
Company types
Generics/Biosimilars Manufacturer
Pharmaceutical company
Contact info
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 41L41, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2022

  • Acetylsalicylic Acid

    Product Acetylsalicylic Acid

    gostro-resistant tablets
  • Valproic Acid/ Sodium Valproate

    Product Valproic Acid/ Sodium Valproate

    gastro-resistant soft capsule, syrup, oral solution, solution for injection, prolonged-release tablets 
  • Oxycodone

    Product Oxycodone

    film-coated tablets, prolonged release tablets, syrup, solution for injection or infusion
  • Morphine

    Product Morphine

    solution for injection
  • Buprenorphine

    Product Buprenorphine

    sublingual tablets